Synthetic Cannabinoid Receptor Agonists (SCRAs)
New Psychoactive Substances June 1, 2026 Philippe Pfeifer, Katharina Elisabeth Grafinger
Abstract Synthetic cannabinoid receptor agonists (SCRAs), originally developed for biomedical research purposes, are now one of the biggest classes of new psychoactive substances (NPS). Due to their higher binding affinity and activity to the cannabinoid receptors, compared to Δ9-THC, they pose a higher pharmacological and toxicological risk for consumers. Different intoxication symptoms (e.g.,...